Back
Bicycle Therapeutics PLC Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
38
BCYC
Bicycle Therapeutics PLC
Last Price:
$8.60
Seasonality Move:
9.16%
7 Day Trial
ALL ACCESS PASS
$
7

Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and BCYC is experiencing slight selling pressure.
Bicycle Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.46 | Sell |
20-day SMA: | 8.13 | Buy |
50-day SMA: | 8.69 | Sell |
200-day SMA: | 17.24 | Sell |
8-day EMA: | 8.28 | Buy |
20-day EMA: | 8.27 | Buy |
50-day EMA: | 9.15 | Sell |
200-day EMA: | 14.91 | Sell |
Bicycle Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 49.89 | Sell |
Chaikin Money Flow: | -52971 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.99 - 8.69) | Buy |
Bollinger Bands (100): | (8.25 - 14.19) | Sell |
Bicycle Therapeutics PLC Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bicycle Therapeutics PLC Stock
Is Bicycle Therapeutics PLC Stock a Buy?
-
Bicycle Therapeutics PLC share price is 8.34 while BCYC 8-day simple moving average is 8.46, which is a Sell signal.
-
The stock price of BCYC is 8.34 while Bicycle Therapeutics PLC 20-day SMA is 8.13, which makes it a Buy.
-
Bicycle Therapeutics PLC 50-day simple moving average is 8.69 while BCYC share price is 8.34, making it a Sell technically.
-
BCYC stock price is 8.34 and Bicycle Therapeutics PLC 200-day simple moving average is 17.24, creating a Sell signal.
BCYC Technical Analysis vs Fundamental Analysis
Sell
38
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC a Buy or a Sell?
-
Bicycle Therapeutics PLC stock is rated a SellThe current Bicycle Therapeutics PLC [BCYC] share price is $8.34. The Score for BCYC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Bicycle Therapeutics PLC Stock Info
Market Cap:
577.6M
Price in USD:
8.34
Share Volume:
497.9K
Bicycle Therapeutics PLC 52-Week Range
52-Week High:
28.67
52-Week Low:
6.10
Sell
38
Bicycle Therapeutics PLC (BCYC)
is a Sell
Bicycle Therapeutics PLC Share Price Forecast
-
What is the Bicycle Therapeutics PLC stock price today?The Bicycle Therapeutics PLC stock price is 8.34 USD today.
-
Will BCYC stock go up or go down?Bicycle Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Bicycle Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bicycle Therapeutics PLC is overvalued.
Is Bicycle Therapeutics PLC Stock a Buy?
-
Bicycle Therapeutics PLC share price is 8.34 while BCYC 8-day exponential moving average is 8.28, which is a Buy signal.
-
The stock price of BCYC is 8.34 while Bicycle Therapeutics PLC 20-day EMA is 8.27, which makes it a Buy.
-
Bicycle Therapeutics PLC 50-day exponential moving average is 9.15 while BCYC share price is 8.34, making it a Sell technically.
-
BCYC stock price is 8.34 and Bicycle Therapeutics PLC 200-day simple moving average is 14.91, creating a Sell signal.
Fundamental Analysis of Bicycle Therapeutics PLC
Is Bicycle Therapeutics PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.
Technical Analysis of Bicycle Therapeutics PLC
Should I short Bicycle Therapeutics PLC stock?
-
BCYC Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Bicycle Therapeutics PLC is a Sell
-
Bicycle Therapeutics PLC Relative Strength Index (RSI) is 49.89, which suggest Bicycle Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Bicycle Therapeutics PLC is (6.99 - 8.69), which suggest Bicycle Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Bicycle Therapeutics PLC is (8.25 - 14.19), which suggest Bicycle Therapeutics PLC is a Sell
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.